Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.

Autor: Sandborn, William J1 (AUTHOR) wsandborn@health.ucsd.edu, Vermeire, Séverine1,2 (AUTHOR), Peyrin-Biroulet, Laurent3,4 (AUTHOR), Dubinsky, Marla C5 (AUTHOR), Panes, Julian6 (AUTHOR), Yarur, Andres7 (AUTHOR), Ritter, Timothy8 (AUTHOR), Baert, Filip9 (AUTHOR), Schreiber, Stefan10 (AUTHOR), Sloan, Sheldon11,12 (AUTHOR), Cataldi, Fabio11,12 (AUTHOR), Shan, Kevin11,12 (AUTHOR), Rabbat, Christopher J11,12 (AUTHOR), Chiorean, Michael13 (AUTHOR), Wolf, Douglas C14 (AUTHOR), Sands, Bruce E15 (AUTHOR), D'Haens, Geert16 (AUTHOR), Danese, Silvio17 (AUTHOR), Goetsch, Martina12,18 (AUTHOR), Feagan, Brian G19 (AUTHOR)
Zdroj: Lancet. Apr2023, Vol. 401 Issue 10383, p1159-1171. 13p.
Databáze: Academic Search Ultimate